MyoGene Therapies

Home
Pipeline
About Us
Contact Us

MyoGene Therapies

Home
Pipeline
About Us
Contact Us

© 2025 MyoGene Therapies

LGMD

MyoGene Therapies

MyoGene’s second-generation vector eliminates
liver toxicity risks, solving the safety issues that
led to past gene therapy failures.

Facebook
X
YouTube
LinkedIn

Home
Pipeline
About Us
Contact Us

Copyright © 2025 ·

MyoGene Therapies

· All rights reserved